SEC Info - Pfizer Inc. - ‘S-8’ on 2/24/23

SEC Info℠

Home

Help

Please Sign In

Pfizer Inc. – ‘S-8’ on 2/24/23 – ‘EX-FILING FEES’

On: Friday, 2/24/23, at 8:02pm ET · As of: 2/27/23 · Effective: 2/27/23 · Accession #: 78003-23-30 · File #: 333-270024

  As Of               Filer                 Filing    For·On·As Docs:Size

 2/27/23  Pfizer Inc.                       S-8         2/27/23    4:104K

Registration Statement – Securities for an Employee Benefit Plan — Form S-8 — SA’33

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-8         Pfizer S-8                                          HTML     73K 
 3: EX-5.1      Opinion of Counsel re: Legality                     HTML     12K 
 4: EX-23.2     Consent of Expert or Counsel                        HTML      6K 
 2: EX-FILING FEES  Filing Fees                                     HTML      9K

‘EX-FILING FEES’ — Filing Fees

This is an HTML Document rendered as filed. [ Alternative Formats ]

<! C: C:

Document

EXHIBIT 107

CALCULATION OF REGISTRATION FEE


Title of Securities To Be Registered	Amount To Be Registered (1)	Proposed Maximum Offering Price Per Share (2)	Proposed Maximum Aggregate Offering Price (2)	Amount of Registration Fee (3)
Common Stock, par value $0.05 per share	26,524,672	$42.49	$1,127,033,313.28	$124,200.00

(1)Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement also covers such additional shares of common stock, par value $0.05 per share (the “Common Stock”), of Pfizer Inc. (the “Registrant”) that may become issuable under the Pfizer Inc. 2019 Stock Plan by reason of certain corporate transactions or events, including any stock dividend, stock split, recapitalization or any other similar transaction effected without the receipt of consideration which results in an increase in the number of the Registrant’s outstanding shares of Common Stock.

(2)Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(h) and (c) under the Securities Act. The maximum offering price per share is based on the average of the high and low prices of the Common Stock as reported on the NYSE on February 23, 2023.

(3)Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act. Calculated in accordance with Section 6 of the Securities Act and Rule 457 under the Securities Act by multiplying 0.00011020 and the proposed maximum aggregate offering price.

Dates Referenced Herein and Documents Incorporated by Reference

This ‘S-8’ Filing	Date	Other Filings

Filed as of / Effective on:	2/27/23
Filed on:	2/24/23	4
	2/23/23	10-K, 4
		List all Filings

1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/09/24  Pfizer Inc.                       S-8         5/09/24    4:173K

8 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/23/23  Pfizer Inc.                       10-K       12/31/22  147:33M
 1/31/23  Pfizer Inc.                       8-K:2,9     1/31/23   12:1.7M
12/13/22  Pfizer Inc.                       8-K:5      12/09/22   12:444K
12/14/20  Pfizer Inc.                       8-K:5,9    12/14/20   13:256K                                   Donnelley … Solutions/FA
 8/09/19  Pfizer Inc.                       S-8 POS     8/09/19    2:104K
 8/08/19  Pfizer Inc.                       S-8         8/08/19    3:145K
 3/14/19  Pfizer Inc.                       DEF 14A     4/25/19    2:13M                                    Command Financial
10/06/97  Pfizer Inc.                       8-A12B                 1:41K

↑Top

Filing Submission 0000078003-23-000030 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)